Kenya's Ministry of Health has announced a temporary shortage of the rotavirus vaccine, impacting the nation's routine immunisation program for infants. The disruption is due to production delays from the vaccine manufacturer, Bharat Biotech.

• Kenya has approximately 4,000 doses of the Rotavac Frozen vaccine remaining, enough for less than one month.
• Health Cabinet Secretary Aden Duale confirmed the shortage, citing production delays from the manufacturer, Bharat Biotech, due to facility upgrades.
• The vaccine manufacturer's delays are expected to affect global deliveries between 2026 and 2027.